UK markets closed

Merck & Co., Inc. (0QAH.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
74.85+24.85 (+49.70%)
At close: 02:41PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 3N/A
S&P500 52-week change 3-8.83%
52-week high 374.85
52-week low 374.85
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 82.52B
% held by insiders 10.10%
% held by institutions 175.09%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 32.64
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022


Profit margin 26.27%
Operating margin (ttm)34.33%

Management effectiveness

Return on assets (ttm)11.73%
Return on equity (ttm)40.93%

Income statement

Revenue (ttm)53.98B
Revenue per share (ttm)21.34
Quarterly revenue growth (yoy)49.60%
Gross profit (ttm)35.46B
Net income avi to common (ttm)13.91B
Diluted EPS (ttm)5.59
Quarterly earnings growth (yoy)35.60%

Balance sheet

Total cash (mrq)8.93B
Total cash per share (mrq)3.53
Total debt (mrq)31.79B
Total debt/equity (mrq)77.64
Current ratio (mrq)1.40
Book value per share (mrq)16.17

Cash flow statement

Operating cash flow (ttm)17.22B
Levered free cash flow (ttm)10.19B